Skip to main content
. 2019 Mar 22;12(3):100018. doi: 10.1016/j.waojou.2019.100018

Table 4.

Regional differences in XLA.

Survival >20y of agea Enteroviral meningoencephalitis Inflammatory bowel disease Arthritis
Africa n = 229 22% 1.3% 1.3% 8.3%
Asia n = 169 39% 0.59% 2.4% 6.5%
Australia n = 7 >75% 0 0 14.3%
Europe n = 186 >75% 0.54% 5.9% 17.2%
North America n = 136 75% 0 2.2% 2.9%
South America n = 56 72% 10.7% 8.9% 7.1%
a

Survival was based on a weighted average of reported categorical responses.